The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

the maker of highly sought GLP-1 drugs Ozempic and Wegovy, which are approved by the FDA to treat diabetes and weight loss, respectively. These drugs, which have seen skyrocketing demand in the U ...

Eli Lilly’s LLY.N powerful weight-loss drug Zepbound hit 77,590 new prescriptions in the U.S. for the week ending March 8, surpassing Novo Nordisk’s NOVOb.CO rival obesity medicine Wegovy for ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

A pharmacist holds a box of Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy ... and Wegovy can run more than $1,000 a month. Ozempic is approved by the U.S. Food ...

Zepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor Wegovy (semaglutide ... registered in the U.S. and other countries. FORTUNE may receive compensation ...

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.